ATE297194T1 - Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate - Google Patents

Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate

Info

Publication number
ATE297194T1
ATE297194T1 AT99670010T AT99670010T ATE297194T1 AT E297194 T1 ATE297194 T1 AT E297194T1 AT 99670010 T AT99670010 T AT 99670010T AT 99670010 T AT99670010 T AT 99670010T AT E297194 T1 ATE297194 T1 AT E297194T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
coated
preparations containing
layer
salts
Prior art date
Application number
AT99670010T
Other languages
English (en)
Inventor
Mendes Carla Patrici Goncalves
Ramalho De Oliveira Mar Caeiro
Original Assignee
Medinfar Produtos Farmaceutico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8242620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE297194(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medinfar Produtos Farmaceutico filed Critical Medinfar Produtos Farmaceutico
Application granted granted Critical
Publication of ATE297194T1 publication Critical patent/ATE297194T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99670010T 1999-12-16 1999-12-16 Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate ATE297194T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99670010A EP1108425B1 (de) 1999-12-16 1999-12-16 Neue stabile mehreinheitliche substituierte Benzimidazole enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ATE297194T1 true ATE297194T1 (de) 2005-06-15

Family

ID=8242620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99670010T ATE297194T1 (de) 1999-12-16 1999-12-16 Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate

Country Status (7)

Country Link
US (1) US6379705B1 (de)
EP (1) EP1108425B1 (de)
AT (1) ATE297194T1 (de)
DE (1) DE69925740T2 (de)
DK (1) DK1108425T3 (de)
ES (1) ES2244167T3 (de)
PT (1) PT1108425E (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation
ES2426723T3 (es) * 2001-10-17 2013-10-24 Takeda Pharmaceutical Company Limited Gránulos que contienen gran cantidad de compuesto químico inestable en medio ácido
KR100479637B1 (ko) * 2002-02-01 2005-03-31 한국화학연구원 란소프라졸을 함유하는 경구제제 및 그의 제조방법
KR100434904B1 (ko) * 2002-05-30 2004-06-11 주식회사 대웅 안정화된 란소프라졸을 함유하는 장용성 제제
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
RU2332237C2 (ru) * 2002-08-02 2008-08-27 Рациофарм Гмбх Фармацевтический препарат, содержащий производное бензимидазола, смешанное с микрокристаллической целлюлозой, и способ его изготовления
US20050191353A1 (en) * 2002-08-16 2005-09-01 Amit Krishna Antarkar Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
WO2004035052A1 (ja) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited 安定な固形製剤
US20040146558A1 (en) * 2003-01-28 2004-07-29 Kyowa Pharmaceutical Co., Ltd. Oral enteric-coated preparation
WO2004066982A1 (en) * 2003-01-31 2004-08-12 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and processes for their preparation
JP4808612B2 (ja) * 2003-04-25 2011-11-02 田辺三菱製薬株式会社 アルキレンジオキシベンゼン誘導体を含む経口投与用組成物
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
CA2558535A1 (en) * 2004-03-03 2005-10-06 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical composition comprising an acid labile drug
ES2376466T3 (es) * 2004-05-07 2012-03-14 Nycomed Gmbh Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación.
CA2469427A1 (en) * 2004-06-01 2005-12-01 Pharmascience Inc. Dry mixed dosage form containing benzimidazole derivatives
US9040564B2 (en) * 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
EP1785135A1 (de) * 2005-11-10 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Neue Lanzoprazol enthaltende stabilisierte galenische Formulierungen und ihre Herstellung
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
CA2718416C (en) * 2008-03-13 2018-01-02 Mallinckrodt Inc. Multi-function, foot-activated controller for imaging system
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
HK1201477A1 (en) 2011-11-02 2015-09-04 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical composition of omeprazole
GB201306720D0 (en) 2013-04-12 2013-05-29 Special Products Ltd Formulation
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3292862A1 (de) 2016-09-07 2018-03-14 Sandoz Ag Omeprazolformulierungen
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
DK0519144T3 (da) * 1991-06-21 1998-03-23 Ilsan Ilac Ve Hammaddeleri San Ny galenisk proces for omeprazol indeholdende pellets
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
DK0723436T3 (da) * 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
PT101826A (pt) * 1996-02-06 1997-09-30 Medinfar Produtos Farmaceutico Processo para a preparacao de microgranulos contendo omeprazole
WO1998019668A1 (en) * 1996-11-06 1998-05-14 Sharmatek, Inc. Delayed delivery system for acid-sensitive drugs
PT101965A (pt) * 1997-02-06 1998-09-30 Medinfar Produtos Farmaceutico Novas formulacoes farmaceuticas estaveis de microgranulos contendo omeprazole

Also Published As

Publication number Publication date
PT1108425E (pt) 2005-10-31
ES2244167T3 (es) 2005-12-01
DK1108425T3 (da) 2005-09-26
DE69925740T2 (de) 2006-05-11
EP1108425A1 (de) 2001-06-20
HK1039742A1 (en) 2002-05-10
EP1108425B1 (de) 2005-06-08
US6379705B1 (en) 2002-04-30
DE69925740D1 (de) 2005-07-14

Similar Documents

Publication Publication Date Title
ATE297194T1 (de) Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate
EP2112920B1 (de) Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
EP0814783B1 (de) Aus mehreren einzeleinheiten zusammengesetzte dosierungsformen enthaltend einem protonen pumpen inhibitor
KR100755154B1 (ko) 경구용 제약학적 서방형 투여 제형
ES2220989T3 (es) Nueva composicion que contiene benzimidazol labil al acido y procedimiento para su preparacion.
ES2189232T5 (es) Microgránulos de omeprazol protegidos gástricamente, procedimiento de obtención y preparaciones farmacéuticas
CA2453117A1 (en) Oral dosage forms comprising a benzimidazole and buffer
US7988999B2 (en) Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
NO20023313D0 (no) Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
SK278566B6 (en) A medicament in the pellet or tablet form for the oral
IS2856B (is) Lyfjablanda úr ómeprasól
BR9910723A (pt) Composição farmacêutica oral, estável, contendo um composto de piridilsulfinil benzimidazol substituìdo
JP2011157390A (ja) 胃液において不溶性の微小顆粒、その調製方法、および薬学的調製物
DE68917738D1 (de) Therapeutisch aktive substituierte Benzimidazole und Verfahren zu ihrer Herstellung.
KR20030059318A (ko) 산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
CA2605839A1 (en) Stabilized composition of a proton pump inhibitor
DE69907479D1 (de) Piroxicam enthaltende gastrointestinale Zubereitung aus merheren Einheiten bestehend
CZ295266B6 (cs) Stabilní galenické přípravky obsahující benzimidazol a způsob jejich přípravy
JP2005522462A (ja) 気道疾患の治療のためのプロトンポンプ阻害剤の使用
WO2019216837A1 (en) Novel pharmaceutical compositions
WO2020022974A2 (en) A pharmaceutical composition comprising prucalopride and a proton pump inhibitor
CA2594185A1 (en) Solid dosage forms comprising a substituted benzimidazole derivative and a buffer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1108425

Country of ref document: EP

RZN Patent revoked